Viewing Study NCT00940303


Ignite Creation Date: 2025-12-24 @ 7:10 PM
Ignite Modification Date: 2026-01-02 @ 1:53 AM
Study NCT ID: NCT00940303
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2009-07-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module